Friday, 21 December 2018

U.S. FDA approves Alexion Pharma's blood disorder drug

The U.S. Food and Drug Administration has approved Alexion Pharmaceuticals Inc's blood disorder drug Ultomiris, the pharma regulator's website showed on Friday.


No comments:

Post a Comment